2023-07-28 15:05:28 ET
- Medicenna Therapeutics press release ( NASDAQ: MDNA ): Q1 GAAP EPS of -$0.04.
For further details see:
Medicenna Therapeutics GAAP EPS of -$0.042023-07-28 15:05:28 ET
For further details see:
Medicenna Therapeutics GAAP EPS of -$0.04Market Wire News is a media platform, the information on this page was provided by SeekingAlpha via Quote Media. Read our full disclaimer.
When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
News, Short Squeeze, Breakout and More Instantly...
Medicenna Therapeutics Corp. Company Name:
MDNA Stock Symbol:
Market:
TORONTO and HOUSTON, Oct. 27, 2023 (GLOBE NEWSWIRE) -- Medicenna Therapeutics Corp. (“Medicenna” or “the Company”) (NASDAQ, TSX: MDNA), a clinical-stage immunotherapy company focused on the development of engineered cytokines, announced today that the Company received ...